ALBANY MOLECULAR RESEARCH ANNOUNCES DRUG DISCOVERY RESEARCH COLLABORATION WITH ALCON

Albany Molecular Research has entered into a two-year research collaboration with Alcon Research to discover and develop ophthalmic pharmaceuticals. Under the terms of the agreement, AMRI will screen samples from its natural product collections, with the goal of identifying and developing lead compounds with desired biological activity against ophthalmic-related biological targets. Additional AMRI compound collections may also be screened under the agreement.

Yahoo News (http://biz.yahoo.com/bw/050107/75300_1.html)